Development of neutralizing and binding antibodies to interferon (IFN) in patients undergoing IFN therapy

Antiviral Research

Volumn 24, Issue 2-3, 1994, Pages 235-244

  Antonelli, Guido ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Antibody; Interferon; Interferon therapy; Viral hepatitis

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DRUG ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON; INTERFERON ANTIBODY; INTERFERON BETA SERINE; INTERLEUKIN 1; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; TUMOR NECROSIS FACTOR ANTIBODY;

ANTIBODY PRODUCTION; CHRONIC HEPATITIS; CLINICAL TRIAL; ENZYME IMMUNOASSAY; HAIRY CELL LEUKEMIA; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SEROCONVERSION;

HEPATITIS, VIRAL, HUMAN; HUMAN; INTERFERONS; NEUTRALIZATION TESTS; SUPPORT, NON-U.S. GOV'T;

HEPATITIS B VIRUS;

EID: 0028246553     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(94)90070-1     Document Type: Article

References (53)

1. Production of Two Human 2′,5′-Oligoadenylate Synthetase Enzymes inEscherichia coli
2. Incidence of anti-IFN alpha neutralizing antibodies in hepatitis patients treated with different IFN alpha preparations
3. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations
4. Relative frequency of non-neutralizing antibodies to interferon in hepatitis patients treated with different IFN alpha preparations
5. Antibodies to interferon alpha in patients
6. Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’
7. Autoantibodies to cytokines friends or foes?
8. Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-alpha subtypes
9. Natural antibodies to IFN-gamma in man and their increase during viral infection
10. Long-term results of interferon therapy in essential mixed cryoglobulinemia
11. In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia
12. Anti-alpha interferon antibodies after alpha interferon treatment in patients with chronic viral hepatitis
13. Natural antibodies to interferon-alpha and interferon-beta are a common feature of inbread mouse strains
14. Low incidence of neutralizing antibody formation to interferon in human recipients
15. Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant m elanoma patients
16. Recombinant leukocyte A interferon (rIFN-alpha-2a) antibody development in advanced renal cell carcinoma (RCC)
17. Anti-interferon antibodies: A perspective
18. Immunogenicity of recombinant DNA human insulin
19. Why are there so many subtypes of alpha-interferons?
20. Antibodies to lymphoblastoid interferon
21. Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C.
22. Randomized study of the duration of treatment with interferon alpha-2b in patients with hairy cell leukemia
23. Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF
24. Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alpha 2a by intramuscolar injection
25. Detection of serum neutralizing antibodies to interferon alfa-2b (Intron A) by means of an enzyme immunoassay
26. The absence of interferon antibody formation in patients receiving human interferon-gamma
27. Evaluation of neutralizing antibodies in patients treated with recombinant interferon-beta
28. Alpha-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma
29. Absence of neutralizing antibodies to interferon in condyloma acuminata and cancer patients treated with natural human leukocyte interferon
30. Long-term followup in a randomized controlled trial of recombinant alpha-interferon in Chinese patients with chronic hepatitis B infection
31. Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection
32. Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection
33. PATIENT WITH CIRCULATING ANTIBODIES TO α-INTERFERON
34. Development of neutralizing interferon antibodies after treatment with recombinant interferon-alpha 2b in patients with malignant carcinoid tumors
35. Antibodies to interferon in man
36. Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon
37. Treatment-induced interferon (IFN)-alpha antibodies, differential neutralizing of the antiproliferative IFN-alpha activity in vitro
38. Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma
39. Alpha interferons in hairy-cell leukemia (HCL): a five years follow up in 100 patients
40. Characterization of anti-interferon-α antibodies appearing during recombinant interferon-α2a treatment
41. Modification of human leukocyte interferon pharmacology with a monoclonal antibody
42. Autoantibodies to crude human leukocyte interferon (IFN) native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors
43. The alpha interferons: Clinical overview
44. Resistance to recombinant interferon alpha-2a in hairy cell leukemia associated with neutralizing anti-interferon antibodies
45. Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia
46. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
47. Interferon neutralizing antibodies in a patient treated with human fibroblast interferon
48. Clinical significance of anti-interferon antibodies during interferon therapy
49. Leukocyte derived interferon-alpha in patients with antibodies to recombinant IFN-alpha 2b
50. Introduction
51. Effective natural interferon-alpha therapy in recombinant interferon-alpha-resistant patients with hairy cell leukemia
52. Detection and incidence of neutralizing antibodies to interferon-alpha-n1